Cyclothiazide
      Cyclothiazide| 
 | 
| Clinical data | 
|---|
| ATC code | 
C03AA09 (WHO)  | 
|---|
| Legal status | 
|---|
| Legal status | 
 | 
|---|
| Identifiers | 
|---|
- 3-(bicyclo[2.2.1]hept-5-en-2-yl)-6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
  
  | 
| CAS Number | 
2259-96-3  Y | 
|---|
| PubChem (CID) | 
2910 | 
|---|
| IUPHAR/BPS | 
4167 | 
|---|
| DrugBank | 
DB00606  N | 
|---|
| ChemSpider | 
4535011  N | 
|---|
| UNII | 
P71U09G5BW  Y | 
|---|
| KEGG | 
D01256  Y | 
|---|
| ChEMBL | 
CHEMBL61593  N | 
|---|
| ECHA InfoCard | 
100.017.146  | 
|---|
| Chemical and physical data | 
|---|
| Formula | 
C14H16ClN3O4S2 | 
|---|
| Molar mass | 
389.88 g/mol | 
|---|
| 3D model (Jmol) | 
Interactive image | 
|---|
O=S(=O)(c1c(Cl)cc2c(c1)S(=O)(=O)NC(N2)C4[C@@H]3\C=C/[C@@H](C3)C4)N  
  | 
InChI=1S/C14H16ClN3O4S2/c15-10-5-11-13(6-12(10)23(16,19)20)24(21,22)18-14(17-11)9-4-7-1-2-8(9)3-7/h1-2,5-9,14,17-18H,3-4H2,(H2,16,19,20)/t7-,8+,9?,14?/m0/s1   NKey:BOCUKUHCLICSIY-QJWLJZLASA-N   N 
  | 
  N Y (what is this?)  (verify) | 
|---|
Cyclothiazide (Anhydron, Acquirel, Doburil, Fluidil, Renazide, Tensodiural, Valmiran) is a benzothiadiazide (thiazide) diuretic and antihypertensive that was originally introduced in the United States in 1963 by Eli Lilly and was subsequently also marketed in Europe and Japan.[1][2] Related drugs include diazoxide, hydrochlorothiazide, and chlorothiazide.[3]
In 1993, it was discovered that cyclothiazide is a positive allosteric modulator of the AMPA and kainate receptors, capable of reducing or essentially eliminating rapid desensitization of the former receptor, and potentiating AMPA-mediated glutamate currents by as much as 18-fold at the highest concentration tested (100 μM).[3][4][5][6] Additionally, in 2003, cyclothiazide was also found to act as a GABAA receptor negative allosteric modulator, potently inhibiting GABAA-mediated currents.[7] In animals it is a powerful convulsant, robustly enhancing epileptiform activity and inducing seizures, but without producing any apparent neuronal death.[8][9]
Cyclothiazide has been found to act as a non-competitive antagonist of the mGluR1.[10] It is selective for mGluR1 over other metabotropic glutamate receptors.[10]
Synthesis
References
- ↑  Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. p. 1932. ISBN 3-88763-075-0. 
 - ↑  Sittig, Marshall (1988). Pharmaceutical manufacturing encyclopedia. Park Ridge, N.J., U.S.A: Noyes Publications. p. 1756. ISBN 0-8155-1144-2. 
 - 1 2  Skolnick, Phil; Palfreyman, Michael G.; Reynolds, Ian J. (1994). Direct and allosteric control of glutamate receptors. Boca Raton: CRC Press. p. 174. ISBN 0-8493-8307-2. 
 - ↑  Yamada KA, Tang CM (September 1993). "Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents". Journal of Neuroscience. 13 (9): 3904–15. PMID 8103555. 
 - ↑  Bertolino M, Baraldi M, Parenti C,  et al. (1993). "Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus". Receptors & Channels. 1 (4): 267–78. PMID 7915948. 
 - ↑  Ströhle, Andreas; Bilkei-Gorzo, A.; Holsboer, Florian (2005). Anxiety and anxiolytic drugs. Berlin: Springer. p. 566. ISBN 3-540-22568-4. 
 - ↑  Deng L, Chen G (October 2003). "Cyclothiazide potently inhibits gamma-aminobutyric acid type A receptors in addition to enhancing glutamate responses". Proceedings of the National Academy of Sciences of the United States of America. 100 (22): 13025–9. doi:10.1073/pnas.2133370100. PMC 240738
. PMID 14534329.  - ↑  Qi J, Wang Y, Jiang M, Warren P, Chen G (March 2006). "Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo". The Journal of Physiology. 571 (Pt 3): 605–18. doi:10.1113/jphysiol.2005.103812. PMC 1805799
. PMID 16423850.  - ↑  Kong S, Qian B, Liu J, Fan M, Chen G, Wang Y (July 2010). "Cyclothiazide induces seizure behavior in freely moving rats". Brain Research. 1355: 207–213. doi:10.1016/j.brainres.2010.07.088. PMC 2947190
. PMID 20678492.  - 1 2  Surin A, Pshenichkin S, Grajkowska E, Surina E, Wroblewski JT (2007). "Cyclothiazide selectively inhibits mGluR1 receptors interacting with a common allosteric site for non-competitive antagonists". Neuropharmacology. 52 (3): 744–54. doi:10.1016/j.neuropharm.2006.09.018. PMC 1876747
. PMID 17095021.  - ↑  Whitehead, C. W.; Traverso, J. J.; Sullivan, H. R.; Marshall, F. J. (1961). "Diuretics. V. 3,4-Dihydro-1,2,4-benzothiadiazine 1,1-Dioxides". The Journal of Organic Chemistry. 26 (8): 2814. doi:10.1021/jo01066a046. 
 
 
 | 
|---|
 | 
Receptor (ligands) | | AMPA |  | 
|---|
  |  | NMDA | 
-  Antagonists: Competitive antagonists: AP5 (APV)
 
-  AP7
 
-  CGP-37849
 
-  CGP-39551
 
-  CGP-39653
 
-  CGP-40116
 
-  CGS-19755
 
-  CPP
 
-  LY-233,053
 
-  LY-235,959
 
-  LY-274,614
 
-  MDL-100,453
 
-  Midafotel (d-CPPene)
 
-  NPC-12,626
 
-  NPC-17,742
 
-  PBPD
 
-  PEAQX
 
-  Perzinfotel
 
-  PPDA
 
-  SDZ-220581
 
-  Selfotel; Noncompetitive antagonists: ARR-15,896
 
-  Caroverine
 
-  Dexanabinol
 
-  FPL-12495
 
-  FR-115,427
 
-  Hodgkinsine
 
-  Magnesium
 
-  MDL-27,266
 
-  NPS-1506
 
-  Psychotridine
 
-  Zinc; Uncompetitive pore blockers: 2-MDP
 
-  3-HO-PCP
 
-  3-MeO-PCE
 
-  3-MeO-PCMo
 
-  3-MeO-PCP
 
-  4-MeO-PCP
 
-  8A-PDHQ
 
-  18-MC
 
-  α-Endopsychosin
 
-  Alaproclate
 
-  Amantadine
 
-  Aptiganel
 
-  Arketamine
 
-  ARL-12,495
 
-  ARL-15,896-AR
 
-  ARL-16,247
 
-  Budipine
 
-  Conaridine
 
-  Delucemine
 
-  Dexoxadrol
 
-  Dextrallorphan
 
-  Dieticyclidine
 
-  Diphenidine
 
-  Dizocilpine
 
-  Ephenidine
 
-  Esketamine
 
-  Etoxadrol
 
-  Eticyclidine
 
-  Fluorolintane
 
-  Gacyclidine
 
-  Ibogaine
 
-  Ibogamine
 
-  Indantadol
 
-  Ketamine
 
-  Ketobemidone
 
-  Lanicemine
 
-  Loperamide
 
-  Memantine
 
-  Methadone (Levomethadone)
 
-  Methorphan (Dextromethorphan
 
-  Levomethorphan)
 
-  Methoxetamine
 
-  Methoxphenidine
 
-  Milnacipran
 
-  Morphanol (Dextrorphan
 
-  Levorphanol)
 
-  NEFA
 
-  Neramexane
 
-  Nitromemantine
 
-  Nitrous oxide
 
-  Noribogaine
 
-  Norketamine
 
-  Orphenadrine
 
-  PCPr
 
-  Pethidine (meperidine)
 
-  Phencyclamine
 
-  Phencyclidine
 
-  Propoxyphene
 
-  Remacemide
 
-  Rhynchophylline
 
-  Rimantadine
 
-  Rolicyclidine
 
-  Sabeluzole
 
-  Tabernanthine
 
-  Tenocyclidine
 
-  Tiletamine
 
-  Tramadol
 
-  Xenon; Glycine site antagonists: 4-Cl-KYN (AV-101)
 
-  5,7-DCKA
 
-  7-CKA
 
-  ACC
 
-  ACEA-1011
 
-  ACEA-1328
 
-  AV-101
 
-  Carisoprodol
 
-  CGP-39653
 
-  CNQX
 
-  DNQX
 
-  Felbamate
 
-  Gavestinel
 
-  GV-196,771
 
-  Kynurenic acid
 
-  Kynurenine
 
-  L-689,560
 
-  L-701,324
 
-  Licostinel (ACEA-1021)
 
-  LU-73,068
 
-  MDL-105,519
 
-  Meprobamate
 
-  MRZ 2/576
 
-  PNQX
 
-  ZD-9379; NR2B subunit antagonists: Besonprodil
 
-  CERC-301 (MK-0657)
 
-  CO-101,244 (PD-174,494)
 
-  Eliprodil
 
-  Haloperidol
 
-  Ifenprodil
 
-  Isoxsuprine
 
-  Nylidrin
 
-  Ro8-4304
 
-  Ro25-6981
 
-  Traxoprodil; Polyamine site antagonists: Arcaine
 
-  Co 101676
 
-  Diaminopropane
 
-  Diethylenetriamine
 
-  Huperzine A
 
-  Putrescine
 
-  Ro 25-6981; Unclassified/unsorted antagonists: Bumetanide
 
-  Chloroform
 
-  Cyclopropane
 
-  D-αAA
 
-  Diethyl ether
 
-  Enflurane
 
-  Ethanol
 
-  Flufenamic acid
 
-  Flupirtine
 
-  Furosemide
 
-  Halothane
 
-  Isoflurane
 
-  Metaphit
 
-  Methoxyflurane
 
-  Niflumic acid
 
-  Pentamidine isethionate
 
-  Piretanide
 
-  Toluene
 
-  Transcrocetin (saffron)
 
-  Trichloroethane
 
-  Trichloroethanol
 
-  Trichloroethylene
 
-  Xylene
  
  | 
|---|
  |  | Kainate |  | 
|---|
  |  | mGlu1 |  | 
|---|
  |  | mGlu2 |  | 
|---|
  |  | mGlu3 |  | 
|---|
  |  | mGlu4 | 
-  Antagonists: CPPG
 
-  MAP4
 
-  MPPG
 
-  MSOP
 
-  MTPG
 
-  UBP-1112
  
  | 
|---|
  |  | mGlu5 |  | 
|---|
  |  | mGlu6 | 
-  Antagonists: CPPG
 
-  MAP4
 
-  MPPG
 
-  MSOP
 
-  MTPG
 
-  UBP-1112
  
  | 
|---|
  |  | mGlu7 | 
-  Antagonists: CPPG
 
-  MAP4
 
-  MMPIP
 
-  MPPG
 
-  MSOP
 
-  MTPG
 
-  UBP-1112
  
  | 
|---|
  |  | mGlu8 | 
-  Antagonists: CPPG
 
-  MAP4
 
-  MPPG
 
-  MSOP
 
-  MTPG
 
-  UBP-1112
  
  | 
|---|
 
  | 
|---|
 | 
Transporter (blockers) |  | 
|---|
 | 
Enzyme (inhibitors) |  | 
|---|
 | 
| Others |  | 
|---|
 | 
See also: GABAergics • GHBergics • Glycinergics  | 
 
 | 
|---|
 | 
Receptor (ligands) |  | Agonists  |  | 
|---|
  |  PAMs  | 
-   (Abridged; see here for a full list): α-EMTBL
 
-  Alcohols (e.g., ethanol)
 
-  Anabolic steroids
 
-  Avermectins (e.g., ivermectin)
 
-  Barbiturates (e.g., phenobarbital)
 
-  Benzodiazepines (e.g., diazepam)
 
-  Bromide compounds (e.g., potassium bromide)
 
-  Carbamates (e.g., meprobamate)
 
-  Carbamazepine
 
-  Chloralose
 
-  Chlormezanone
 
-  Clomethiazole
 
-  Dihydroergolines (e.g., ergoloid (dihydroergotoxine))
 
-  Etazepine
 
-  Etifoxine
 
-  Fenamates (e.g., mefenamic acid)
 
-  Flavonoids (e.g., apigenin, hispidulin)
 
-  Fluoxetine
 
-  Flupirtine
 
-  Imidazoles (e.g., etomidate)
 
-  Kava constituents (e.g., kavain)
 
-  Lanthanum
 
-  Loreclezole
 
-  Monastrol
 
-  Neuroactive steroids (e.g., allopregnanolone, cholesterol)
 
-  Niacin
 
-  Nicotinamide (niacinamide)
 
-  Nonbenzodiazepines (e.g., β-carbolines (e.g., abecarnil), cyclopyrrolones (e.g., zopiclone), imidazopyridines (e.g., zolpidem), pyrazolopyrimidines (e.g., zaleplon))
 
-  Norfluoxetine
 
-  Petrichloral
 
-  Phenols (e.g., propofol)
 
-  Phenytoin
 
-  Piperidinediones (e.g., glutethimide)
 
-  Propanidid
 
-  Pyrazolopyridines (e.g., etazolate)
 
-  Quinazolinones (e.g., methaqualone)
 
-  Retigabine (ezogabine)
 
-  ROD-188
 
-  Skullcap constituents (e.g., baicalin)
 
-  Stiripentol
 
-  Sulfonylalkanes (e.g., sulfonmethane (sulfonal))
 
-  Topiramate
 
-  Valerian constituents (e.g., valerenic acid)
 
-  Volatiles/gases (e.g., chloral hydrate, chloroform, diethyl ether, paraldehyde, sevoflurane)
  
  | 
|---|
  |  Antagonists  |  | 
|---|
  |  NAMs  | 
-  1,3M1B
 
-  3M2B
 
-  17-Phenylandrostenol
 
-  α5IA (LS-193,268)
 
-  β-CCB
 
-  β-CCE
 
-  β-CCM
 
-  β-CCP
 
-  β-EMGBL
 
-  Anabolic steroids
 
-  Amiloride
 
-  Anisatin
 
-  β-Lactams (e.g., penicillins, cephalosporins, carbapenems)
 
-  Basmisanil
 
-  Bemegride
 
-  Bilobalide
 
-  CHEB
 
-  Cicutoxin
 
-  Cloflubicyne
 
-  Cyclothiazide
 
-  DHEA
 
-  DHEA-S
 
-  Dieldrin
 
-  (+)-DMBB
 
-  DMCM
 
-  DMPC
 
-  EBOB
 
-  Etbicyphat
 
-  FG-7142 (ZK-31906)
 
-  Fiproles (e.g., fipronil)
 
-  Flavonoids (e.g., amentoflavone, oroxylin A)
 
-  Flumazenil
 
-  Fluoroquinolones (e.g., ciprofloxacin)
 
-  Flurothyl
 
-  Furosemide
 
-  Iomazenil (123I)
 
-  Isoallopregnanolone
 
-  Isopregnanolone (sepranolone)
 
-  L-655,708
 
-  Laudanosine
 
-  Leptazol
 
-  Lindane
 
-  MaxiPost
 
-  Morphine
 
-  Morphine-3-glucuronide
 
-  MRK-016
 
-  Naloxone
 
-  Naltrexone
 
-  Nicardipine
 
-  Non-steroidal antiandrogens (e.g., apalutamide, bicalutamide, enzalutamide, flutamide, nilutamide)
 
-  Oenanthotoxin
 
-  Pentetrazol (metrazol)
 
-  Phenylsilatrane
 
-  Picrotoxin (i.e., picrotin and picrotoxinin)
 
-  Pregnenolone sulfate
 
-  Propybicyphat
 
-  PWZ-029
 
-  Radequinil
 
-  Ro 15-4513
 
-  Ro 19-4603
 
-  RO4882224
 
-  RO4938581
 
-  Sarmazenil
 
-  SCS
 
-  Suritozole
 
-  TB-21007
 
-  TBOB
 
-  TBPS
 
-  TCS-1105
 
-  Terbequinil
 
-  TETS
 
-  Thujone
 
-  U-93631
 
-  Zinc
 
-  ZK-93426
  
  | 
|---|
 
  | 
|---|
  |   | Agonists  |  | 
|---|
  |  PAMs  |  | 
|---|
  |  Antagonists  |  | 
|---|
  |  NAMs  |  | 
|---|
 
  | 
|---|
  |   | Agonists  |  | 
|---|
  |  Antagonists  |  | 
|---|
  |  NAMs  |  | 
|---|
  |  PAMs  |  | 
|---|
 
  | 
|---|
 
  | 
|---|
 | 
Transporter (blockers) |  | 
|---|
 | 
Enzyme (inhibitors) |  | 
|---|
 | 
| Others | Precursors  |  | 
|---|
  |  Analogues  |  | 
|---|
  |  Others  |  | 
|---|
 
  | 
|---|
 | 
See also: GHBergics • Glutamatergics • Glycinergics  |